Loading insider details...
Beta
Latest Form 4 (Oct 15, 2026): Exercise/Conversion of 1,452 NRIX shares, $2.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 1,452 | $2.7K |
| Sep 1, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 1,452 | $2.7K |
| Aug 5, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 4,356 | $8.1K |
| Aug 5, 2026 | Nurix Therapeutics, Inc. (NRIX) | Sale | 1,500 | $35.8K |
| Jul 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 3,750 | n/a |
| Jun 25, 2026 | Nurix Therapeutics, Inc. (NRIX) | Sale | 5,394 | $107.9K |
| Apr 30, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 2,000 | n/a |
| Feb 10, 2026 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 93,750 | n/a |
| Feb 4, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 31,333 | $26.3K |
| Jan 31, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 3,207 | n/a |